CO5040084A1 - Forma polimorfa del hidrogenosulfato de clopidogrel - Google Patents

Forma polimorfa del hidrogenosulfato de clopidogrel

Info

Publication number
CO5040084A1
CO5040084A1 CO99037210A CO99037210A CO5040084A1 CO 5040084 A1 CO5040084 A1 CO 5040084A1 CO 99037210 A CO99037210 A CO 99037210A CO 99037210 A CO99037210 A CO 99037210A CO 5040084 A1 CO5040084 A1 CO 5040084A1
Authority
CO
Colombia
Prior art keywords
polymorm
hydrogenosulphate
clopidogrel
clopidogrel hydrogenosulphate
hydrogensulfate
Prior art date
Application number
CO99037210A
Other languages
English (en)
Inventor
Andre Bousquet
Bertrand Castro
Jean Claude Saint
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9527349&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5040084(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of CO5040084A1 publication Critical patent/CO5040084A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Abstract

Nuevo polimorfo ortorrómbico del hidrogenosulfato de clopidogrelo hidrogenosulfalto de (+)-(S)-a-(2-clorofenil)-4,5,6,7-tetrahidrotieno[3,2-c]piridinil-5-acetato de metilo y un procedimiento para su preparación.
CO99037210A 1998-06-15 1999-06-15 Forma polimorfa del hidrogenosulfato de clopidogrel CO5040084A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9807464A FR2779726B1 (fr) 1998-06-15 1998-06-15 Forme polymorphe de l'hydrogenosulfate de clopidogrel

Publications (1)

Publication Number Publication Date
CO5040084A1 true CO5040084A1 (es) 2001-05-29

Family

ID=9527349

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99037210A CO5040084A1 (es) 1998-06-15 1999-06-15 Forma polimorfa del hidrogenosulfato de clopidogrel

Country Status (44)

Country Link
US (2) US6429210B1 (es)
EP (1) EP1087976B1 (es)
JP (1) JP3641584B2 (es)
KR (1) KR100511238B1 (es)
CN (1) CN1128805C (es)
AP (1) AP1344A (es)
AR (1) AR014854A1 (es)
AT (1) ATE222256T1 (es)
AU (1) AU752170B2 (es)
BG (1) BG64508B1 (es)
BR (1) BR9911219A (es)
CA (1) CA2334870C (es)
CO (1) CO5040084A1 (es)
CZ (1) CZ299654B6 (es)
DE (1) DE69902536T2 (es)
DK (1) DK1087976T3 (es)
DZ (1) DZ2817A1 (es)
EA (1) EA002386B1 (es)
EE (1) EE03972B1 (es)
EG (1) EG24015A (es)
ES (1) ES2181439T3 (es)
FR (1) FR2779726B1 (es)
HK (1) HK1033829A1 (es)
HR (1) HRP20000863B1 (es)
HU (1) HU225871B1 (es)
ID (1) ID28264A (es)
IL (2) IL139790A0 (es)
IS (1) IS2469B (es)
ME (1) ME00686B (es)
MY (1) MY129439A (es)
NO (1) NO327161B1 (es)
NZ (1) NZ507914A (es)
OA (1) OA11567A (es)
PL (1) PL201894B1 (es)
PT (1) PT1087976E (es)
RS (1) RS49870B (es)
SA (1) SA99200321B1 (es)
SK (1) SK286340B6 (es)
TR (1) TR200003417T2 (es)
TW (1) TW562805B (es)
UA (1) UA70323C2 (es)
UY (1) UY25693A1 (es)
WO (1) WO1999065915A1 (es)
ZA (1) ZA200006386B (es)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792836B3 (fr) 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
CA2363053C (en) * 2001-11-09 2011-01-25 Bernard Charles Sherman Clopidogrel bisulfate tablet formulation
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
ES2316650T3 (es) * 2001-12-18 2009-04-16 Teva Pharmaceutical Industries Ltd. Polimorfos de hidrogenosulfato de clopidogrel.
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
HUP0200438A3 (en) * 2002-02-06 2003-10-28 Egis Gyogyszergyar Nyilvanosan Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
ATE494284T1 (de) 2002-04-16 2011-01-15 Schering Corp Tricyclischer thrombinrezeptorantagonist
TW200404802A (en) * 2002-05-31 2004-04-01 Schering Corp Xanthine phosphodiesterase V inhibitor polymorphs
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
CZ297472B6 (cs) * 2002-08-27 2006-12-13 Zentiva, A.S. Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I
AU2003270861A1 (en) * 2002-10-02 2004-04-23 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
ITMI20022228A1 (it) * 2002-10-21 2004-04-22 Dinamite Dipharma S P A Sali di clopidogrel con acidi alchil-solforici.
AU2003285841A1 (en) * 2002-11-28 2004-06-18 Anpharm Przedsiebiorstwo Farmaceutyczne S.A. A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate
DE10307343B4 (de) * 2003-02-21 2005-10-06 Volkswagen Ag On-Board-Diagnosevorrichtung und On-Board-Diagnoseverfahren für Kraftfahrzeuge
US20060100231A1 (en) * 2003-03-10 2006-05-11 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
EP1603920A1 (en) 2003-03-12 2005-12-14 Cadila Healthcare Ltd. Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
WO2004106344A2 (en) * 2003-04-25 2004-12-09 Cadila Healthcare Limited Salts of clopidogrel and process for preparation
CZ200641A3 (cs) * 2003-07-02 2006-05-17 EGIS Gyógyszergyár Rt. Zpusob prípravy krystalického polymorfu inhibitoru srázení krevních desticek
CA2530446A1 (en) 2003-07-02 2005-01-13 Egis Gyogyszergyar Rt. Process for the preparation of amorphous form of a platelet aggregation inhibitor drug
EP1651646B1 (en) * 2003-08-04 2012-05-09 Wockhardt Limited A novel process for the manufacture of (+)-(s)-clopidogrel bisulfate form-i
DE10337773A1 (de) * 2003-08-13 2005-03-24 Krka Tovarna Zdravil, D.D. Kristallisation von festen Formen von Clopidogrel-Additionssalzen
GB0321256D0 (en) * 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
EP1680430B1 (en) * 2003-11-03 2010-01-20 Cadila Healthcare Ltd. Processes for preparing form i of (s)-(+)- clopidogrel bisulfate
CA2457459A1 (en) * 2004-02-11 2005-08-11 Brantford Chemicals Inc. Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
JP2007523203A (ja) * 2004-02-24 2007-08-16 ジークフリート・ジェネリクス・インターナショナル・アクチェンゲゼルシャフト クロピドグレルの薬理学的に許容できる塩
US7629465B2 (en) * 2004-03-05 2009-12-08 Ipca Laboratories Ltd. Industrial process for preparation of Clopidogrel hydrogen sulphate
JP4550884B2 (ja) 2004-04-09 2010-09-22 ハンミ ファーム． シーオー．， エルティーディー． 結晶性クロピドグレルナフタレンスルホン酸塩又はその水和物、その製造方法及びそれを含む医薬組成物
US7999106B2 (en) 2004-04-19 2011-08-16 Krka, Tovarna Zdravil, D.D., Novo Mesto Processes for the preparation of clopidogrel hydrogen sulfate polymorphic form I
BRPI0510008A (pt) * 2004-04-20 2007-09-18 Sanofi Aventis sal de clopidogrel e formas polimórficas deste
CN1997648A (zh) * 2004-04-20 2007-07-11 赛诺菲-安万特 (+)－(S)－α－(2－氯苯基)－6,7－二氢噻吩并[3,2－C]吡啶－5(4H)乙酸甲酯氢溴酸盐，即氯吡格雷氢溴酸盐的多晶型物
US7829720B2 (en) * 2004-05-04 2010-11-09 Bristol-Myers Squibb Company Process for preparing atazanavir bisulfate and novel forms
US20060154957A1 (en) * 2004-09-21 2006-07-13 Nina Finkelstein Crystalline clopidogrel hydrobromide and processes for preparation thereof
US7446200B2 (en) * 2004-10-04 2008-11-04 Usv, Ltd. Rapid resolution process of clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph-form I
AU2005327776A1 (en) * 2005-02-15 2006-08-24 Usv Limited Rapid resolution process for clopidogrel base and a process for preparation of Clopidogrel bisulfate polymorph - Form I
EP1693375A1 (en) * 2005-02-21 2006-08-23 KRKA, tovarna zdravil, d.d., Novo mesto Process for preparing clopidrogel hydrogen sulfate of form I
TW200640932A (en) * 2005-02-24 2006-12-01 Teva Pharma Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
US7772398B2 (en) * 2005-03-11 2010-08-10 Dr. Reddy's Laboratories, Inc. Process for making crystalline form I of clopidogrel hydrogen sulphate
CN101212954A (zh) * 2005-05-10 2008-07-02 伊兰制药国际有限公司 纳米粒氯吡格雷制剂
CN101237868A (zh) * 2005-06-13 2008-08-06 伊兰制药国际有限公司 纳米粒氯吡格雷和阿司匹林组合制剂
KR20070009851A (ko) * 2005-07-14 2007-01-19 씨제이 주식회사 클로피도그렐 황산수소염 함유 약학 조성물
WO2007052300A2 (en) 2005-09-05 2007-05-10 Cadila Healthcare Limited Processes for the preparation of different forms of (s)-(+)-clopidogrel besylate
EP1926736A4 (en) * 2005-09-21 2010-08-25 Chong Kun Dang Pharm Corp NEW RESINATE COMPLEX OF S-CLOPIDOGREL AND METHOD FOR THE PRODUCTION THEREOF
WO2007091253A2 (en) * 2006-02-06 2007-08-16 C.T.S. Ltd. Pharmaceutical compositions comprising clopidogrel and vitamins which reduce homocysteine levels
US20070225320A1 (en) * 2006-03-27 2007-09-27 Eswaraiah Sajja Process for preparing clopidogrel
JP2009532462A (ja) * 2006-04-05 2009-09-10 カディラ・ヘルスケア・リミテッド 調節放出クロピドグレル製剤
KR20090013794A (ko) * 2006-04-27 2009-02-05 인드-스위프트 래버러토리즈 리미티드 클로피도그렐 히드로겐 설페이트의 다형태의 제조방법
EP2044066A2 (en) * 2006-06-06 2009-04-08 Bristol-Myers Squibb Company Crystalline forms of n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl] thio]-2-thiazolyl]-4-piperidinecarboxamide
US20090247569A1 (en) * 2006-08-03 2009-10-01 Claude Singer Process for Preparing Clopidogrel Bisulphate
DK2064217T3 (da) * 2006-09-04 2011-05-09 Ranbaxy Lab Ltd Forbedret fremgangsmåde til fremstilling af clopidogrel og dets farmaceutisk acceptable salte
SI22383A (sl) * 2006-09-22 2008-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze klopidogrela in nove oblike njegovih farmacevtsko sprejemljivih soli
WO2008060934A2 (en) * 2006-11-14 2008-05-22 Acusphere, Inc. Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration
KR20080055356A (ko) * 2006-12-15 2008-06-19 에스케이케미칼주식회사 보관안정성이 우수한 클로피도그렐 함유 포접 복합체
CA2673228A1 (en) * 2006-12-22 2008-07-03 Schering Corporation Disintegration promoters in solid dose wet granulation formulations
EP2114957A4 (en) * 2007-01-29 2011-06-08 Ipca Lab Ltd PROCESS FOR THE PREPARATION OF A CRYSTALLINE FORM 1 OF A CLOPIDOGREL HYDROGEN SULFATE
EP1970054A3 (en) 2007-03-14 2009-06-03 Ranbaxy Laboratories Limited Clopidogrel tablets
PL382055A1 (pl) * 2007-03-23 2008-09-29 Koźluk Tomasz Nobilus Ent Sposób wytwarzania formy krystalicznej 1 wodorosiarczanu klopidogrelu
KR20160033792A (ko) 2007-04-27 2016-03-28 사이덱스 파마슈티칼스, 인크. 클로피도그렐 및 설포알킬 에테르 사이클로덱스트린을 함유하는 제형 및 사용 방법
WO2009080469A1 (en) * 2007-12-24 2009-07-02 Sandoz Ag Process for the preparation of clopidogrel bisulphate form i
EP2095815B1 (en) 2008-02-26 2011-10-26 Laboratorios Lesvi, S.L. Pharmaceutical formulations containing clopidogrel
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
CA2758322C (en) 2009-04-10 2019-04-02 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (mmp-1)
US8236782B2 (en) 2009-05-13 2012-08-07 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
WO2011010318A1 (en) * 2009-07-23 2011-01-27 Praveen Laboratories Private Limited Process for the preparation of clopidogrel polymorphous form 1 using seed chrystals
WO2011042804A2 (en) 2009-10-08 2011-04-14 Jubliant Life Sciences Limited An improved process for the preparation of clopidogrel hydrogen sulfate form i
KR101130445B1 (ko) * 2009-10-29 2012-03-27 동아제약주식회사 클로피도그랠 황산수소염 ⅰ형 제조방법
WO2011051976A2 (en) 2009-10-30 2011-05-05 Matrix Laboratories Ltd An improved process for the preparation of clopidogrel bisulfate form i
CN101766573B (zh) 2010-02-05 2013-02-13 上海安必生制药技术有限公司 硫酸氢氯吡格雷固体制剂的制备工艺
WO2011125069A1 (en) 2010-03-22 2011-10-13 Rpg Life Sciences Limited A process for preparation of crystalline form i of clopidogrel bisulfate
EP2560644B1 (en) 2010-04-19 2016-06-29 Cadila Healthcare Limited A pharmaceutical composition comprising antiplatelet agents and an erythropoiesis stimulating agent
EP2675813A4 (en) 2011-06-27 2014-04-30 Ipca Lab Ltd ANTI THROMBOSIS CONNECTIONS
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법
CN102367257B (zh) * 2011-11-21 2014-05-07 天津红日药业股份有限公司 氯吡格雷盐酸盐的单晶晶型，它们的制备及应用
WO2014118802A1 (en) 2013-01-31 2014-08-07 Pharmazell Gmbh An improved process for the preparation of clopidogrel bisulfate form-i
WO2015015062A1 (fr) 2013-08-02 2015-02-05 Sanofi Comprime pharmaceutique comprenant de l'acide acetylsalicylique et du clopidogrel
CN103524528A (zh) * 2013-09-16 2014-01-22 吉林省博大伟业制药有限公司 一种改进的ⅱ型硫酸氢氯吡格雷结晶制备方法
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
KR101710922B1 (ko) 2015-06-03 2017-02-28 경동제약 주식회사 클로피도그렐 황산염 결정형 i형의 제조방법
CN107698620A (zh) 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
US20200129440A1 (en) 2017-01-23 2020-04-30 Dong Wha Pharm. Co., Ltd. Complex formulation comprising hmg-coa reductase inhibitor and clopidogrel
CN107163060B (zh) * 2017-05-24 2021-03-02 常州制药厂有限公司 一种硫酸氢氯吡格雷晶型ii制备方法
CN107337683B (zh) * 2017-08-16 2019-08-16 中荣凯特（北京）生物科技有限公司 一种噻吩并吡啶类衍生物硫酸氢盐的晶型ⅱ及其制备方法和应用
CN109438467B (zh) * 2018-11-14 2021-03-26 四川青木制药有限公司 一种硫酸氢氯吡格雷ⅱ型球形结晶的制备方法
US20230059869A1 (en) 2021-08-03 2023-02-23 Liqmeds Worldwide Limited Oral pharmaceutical solution of clopidogrel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2664276B1 (fr) * 1990-07-04 1992-10-23 Sanofi Sa Derive thienyl-2 glycidique, son procede de preparation et son utilisation comme intermediaire de synthese.

Also Published As

Publication number Publication date
SK19092000A3 (sk) 2001-05-10
AU4048399A (en) 2000-01-05
NO20006395L (no) 2001-02-15
IL139790A (en) 2006-10-05
BG104987A (en) 2001-11-30
DZ2817A1 (fr) 2004-06-02
CZ299654B6 (cs) 2008-10-08
NZ507914A (en) 2002-11-26
ID28264A (id) 2001-05-10
EP1087976A1 (fr) 2001-04-04
HRP20000863B1 (en) 2003-04-30
AP2000001979A0 (en) 2000-12-31
CN1305483A (zh) 2001-07-25
OA11567A (en) 2004-05-24
NO327161B1 (no) 2009-05-04
US20020198229A1 (en) 2002-12-26
KR100511238B1 (ko) 2005-08-31
TR200003417T2 (tr) 2001-03-21
IL139790A0 (en) 2002-02-10
AR014854A1 (es) 2001-04-11
MY129439A (en) 2007-04-30
HRP20000863A2 (en) 2001-10-31
FR2779726B1 (fr) 2001-05-18
PL201894B1 (pl) 2009-05-29
CA2334870C (en) 2005-03-15
BG64508B1 (bg) 2005-05-31
ME00686B (me) 2008-08-07
DE69902536D1 (en) 2002-09-19
EA200001187A1 (ru) 2001-08-27
KR20010052835A (ko) 2001-06-25
UA70323C2 (uk) 2004-10-15
HK1033829A1 (en) 2001-09-28
JP2002518399A (ja) 2002-06-25
US6429210B1 (en) 2002-08-06
TW562805B (en) 2003-11-21
HUP0104343A2 (hu) 2002-03-28
BR9911219A (pt) 2001-03-06
HU225871B1 (en) 2007-11-28
PL344998A1 (en) 2001-11-19
YU77700A (sh) 2003-04-30
CN1128805C (zh) 2003-11-26
EE03972B1 (et) 2003-02-17
ATE222256T1 (de) 2002-08-15
PT1087976E (pt) 2002-11-29
EA002386B1 (ru) 2002-04-25
UY25693A1 (es) 2000-03-31
SK286340B6 (en) 2008-07-07
AP1344A (en) 2004-12-15
EP1087976B1 (fr) 2002-08-14
US6504030B1 (en) 2003-01-07
FR2779726A1 (fr) 1999-12-17
RS49870B (sr) 2008-08-07
IS2469B (is) 2008-12-15
CA2334870A1 (en) 1999-12-23
IS5716A (is) 2000-11-17
ZA200006386B (en) 2001-05-07
EE200000745A (et) 2002-04-15
HUP0104343A3 (en) 2003-03-28
EG24015A (en) 2008-03-24
WO1999065915A1 (fr) 1999-12-23
DE69902536T2 (de) 2003-03-13
AU752170B2 (en) 2002-09-05
NO20006395D0 (no) 2000-12-14
DK1087976T3 (da) 2002-12-02
JP3641584B2 (ja) 2005-04-20
SA99200321B1 (ar) 2006-10-11
CZ20004637A3 (cs) 2001-04-11
ES2181439T3 (es) 2003-02-16

Similar Documents

Publication Publication Date Title
CO5040084A1 (es) Forma polimorfa del hidrogenosulfato de clopidogrel
ATE233265T1 (de) Thienopyrimidine
ES2159346T3 (es) Formas cristalinas de un derivado de tieno(2,3-b)(1,5)benzodiazepina y procedimiento para su preparacion.
DE60103770D1 (de) Botulinumtoxin zur behandlung endokriner erkrankungen
ATE246689T1 (de) Thienopyrimidine mit pde v inhibierender wirkung
GT199900013A (es) Tratamiento de la disfuncion sexual femenina.
AU2002228991A1 (en) Methods for treating diseases caused by deficiencies of alpha-l-iduronidase
IL145549A0 (en) Thienopyrimidine compounds, their production and use
AU2001288271A1 (en) Methods for treating inflammatory diseases
SI1513846T1 (sl) Postopek za pripravo olanzapina form I
GB2366831B (en) Water Butts
MXPA04012200A (es) Proceso para preparacion de olanzapina e intermediario de la misma.
PL360368A1 (en) Treatment of urinary dysfunction
AU2001261519A1 (en) Methods of affecting laminin 5 processing
IL155769A0 (en) Method for the treatment of inflammation
SI1259515T1 (en) Thienopyridine derivatives and their use as anti-inflammatory agents
HUP0102805A3 (en) Thienopyridine compounds, their production and use
DK0831835T3 (da) Behandling af anorexia
PL345074A1 (en) Thienopyridine compounds, their production and use
ECSP961694A (es) Procedimeinto para preparar olanzapina (caso x - 9992m)
ID27128A (id) Proses pembuatan penghambat 5-lipoksigenase yang memiliki sistem-sistem cincin heterosiklus yang bervariasi
AU2001293719A1 (en) Thienopyrimidine
ZA200202868B (en) Use of thienopyrimidines.
DK1392698T3 (da) Fremgangsmåde til fremstilling af 6-aryl-4H-s-triazolo-[3,4-c]thieno[2,3-e]-1,4-diazepiner
AU2002219247A1 (en) Use of levosimendan for treating erictile dysfunction